https://orcid.org/0000-0002-6695-032X
References
- Whittum M, Schikler R, Fanarjian N, Rapkin R, Nguyen BT. The history of female surgical sterilization. J Gynecol Surg. 2021;37(6):459–463. doi:10.1089/gyn.2021.0101
- Vessey MD, Doll R. Investigation of relation between use of oral contracetives and thromboembolic disease. A further report. BMJ. 1969;2(5658):651–657. doi:10.1136/bmj.2.5658.651
- Jick H, Jick SS, Gurewich V, Wald-Myers M, Vasilakis V. Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995;346(87900):1589–1593. doi:10.1016/50140-6736(95)91928-7
- Morimont L, Creinin MD, Gaspard U, Foidart J-M, Douxfils J. Hormonal therapies and venous thrombosis: estrogen matters! Res Pract Thromb Haemost. 2023;7(1):e100021. doi:10.1016/j.rpth.2022.100021
- Douxfils J, Morimont L, Creinin MD, Gaspard U, Foidart J-M. Hormonal therapies and venous thrombosis: considerations for prevention and management-A reappraisal. Res Pract Thromb Haemost. 2023;e10015. doi:10.1016/j.rpth.2023.1000155
- Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet. 1992;339(8796):785–788. doi:10.1016/0140-6736(92)91904-m
- Short RV. Breast feeding. Sci Am. 1984;250(4):35–41. doi:10.1038/scientificamerican0484-35
- Graziotten A. The shorter, the better: a review of the evidence for a shorter contraceptive hormone-free interval. Eur J Cont Reprod Healthc. 2016;21(2):93–105. doi:10.3109/13697137.2015.1079408
- Goldstuck ND. Modern menstruation: is it abnormal and unhealthy? Med Hypoth. 2020;144:e109955. doi:10.1016/j.mehy.2020.109955
- Bahamondes L, Bahamondes MV, Shulman LP. Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Hum Reprod Update. 2015;21(5):640–651. doi:10.1093/humupd/dmv023
- Goldstuck ND. The levonorgestrel-releasing intrauterine system 52mg as a contraceptive versus a therapeutic: essential differences and perspectives. Eur J Cont Reprod Healthc. 2023;28(3):177–183. doi:10.1080/13625187.2023.2197091
- Soini T, Hurskainen R, Grenman S, Maenpaa J, Paavonen J, Pukkala E. Cancer risk in women using the levonorgestrel intrauterine system in Finland. Obstet Gynecol. 2014;124(2):292–299. doi:10.1097/AOG.0000000000000356
- Chen BA, Kimble T, Harris LH, Kerns JL, Olariu AI, Creinin MD. Levonorgestrel 52-mg intrauterine device efficacy and safety after more than 8 years of use. Obstet Gynecol. 2023;141:1004–1006. doi:10.1097/AOG.0000000000005147
- Stone R, Sakran JV, Roche KL. Salpingectomy in ovarian cancer prevention. JAMA. 2023;329(23):2015–2016.
- Kahn RM, Gordhandas S, Godwin K, et al. Salpingectomy for the primary prevention of ovarian cancer: a systematic review. JAMA Surg. 2023. doi:10.1001/jamasurg.2023.4164
- Creinin MD, Hou MY. Comparing IUC and tubal ligation. J Gen Intern Med. 2022;38(1):239. doi:10.1007/s11606-022-07839-0